BATM Advanced Communications（BVCL.F）株式概要BATM Advanced Communications Ltd.は、その子会社とともに、イスラエル、米国、欧州でリアルタイム技術の開発、製造、マーケティングを行っている。 詳細BVCL.F ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長3/6過去の実績0/6財務の健全性3/6配当金0/6報酬収益は年間132.36%増加すると予測されています リスク分析株式の流動性は非常に低い 意味のある時価総額がありません ( $65M )すべてのリスクチェックを見るBVCL.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.00199.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-13m184m2016201920222025202620282031Revenue US$78.4mEarnings US$8.3mAdvancedSet Fair ValueView all narrativesBATM Advanced Communications Ltd. 競合他社GenasysSymbol: NasdaqCM:GNSSMarket cap: US$77.8mWestell TechnologiesSymbol: OTCPK:WSTLMarket cap: US$76.6mPicoCELASymbol: NasdaqCM:PCLAMarket cap: US$38.7mFranklin WirelessSymbol: NasdaqCM:FKWLMarket cap: US$31.2m価格と性能株価の高値、安値、推移の概要BATM Advanced Communications過去の株価現在の株価UK£0.00152週高値UK£0.1852週安値UK£0.0006ベータ0.731ヶ月の変化0%3ヶ月変化n/a1年変化n/a3年間の変化n/a5年間の変化-99.90%IPOからの変化-99.62%最新ニュースお知らせ • Nov 06BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israelお知らせ • Oct 08Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million.DR.Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million on October 6, 2025. Under the terms of the Sale Agreement, the Group will sell AMS to Dr. Zvi Marom, a non-executive director and significant shareholder of the Group, in exchange for his entire shareholding of 96,794,500 ordinary shares of in BATM, representing c. 22.2% of the existing issued share capital. The transaction values AMS at £17.6m, based on the closing price of the Group's Ordinary Shares. Following completion, Dr. Marom will cease to be a shareholder of the Group and will resign as a director of the Group. The completion of the sale is subject to the approval of shareholders at a general meeting and and all other legal and regulatory requirements; the Board will issue a circular to convene this general meeting in due course. Mark Percy, Anita Ghanekar, James Thomas acted as advisor to BATM Advanced Communications.お知らせ • Sep 27BATM Advanced Communications Ltd. Announces Board and Committee ChangesBATM Advanced Communications Ltd. announced that Harel Locker is retiring from his position as an external director, as defined under Israeli law, of the Group with immediate effect. Mr. Locker completes his third three-year term as an external director of BATM. External directors under Israeli law are appointed for a minimum of one three-year term, which may be extended by the company (subject to shareholder approval) for no more than two additional terms of three years each. The Board will propose the appointment of a new external director for approval by shareholders at the Group's next annual general meeting. Following Mr. Locker's retirement from the Board, Prof. Varda Shalev, an external director of BATM, will assume the role of Interim Chair of the Audit Committee and a permanent chair will be appointed in due course.お知らせ • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025お知らせ • Jun 23+ 1 more updateBATM Advanced Communications Ltd. announces resignation of Ran Noy as Director, Effective 23 June 2025BATM Advanced Communications Ltd. announced that Ran Noy has resigned as Chief Financial Officer and a Director of the Group, effective 23 June 2025.お知らせ • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025最新情報をもっと見るRecent updatesお知らせ • Nov 06BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israelお知らせ • Oct 08Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million.DR.Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million on October 6, 2025. Under the terms of the Sale Agreement, the Group will sell AMS to Dr. Zvi Marom, a non-executive director and significant shareholder of the Group, in exchange for his entire shareholding of 96,794,500 ordinary shares of in BATM, representing c. 22.2% of the existing issued share capital. The transaction values AMS at £17.6m, based on the closing price of the Group's Ordinary Shares. Following completion, Dr. Marom will cease to be a shareholder of the Group and will resign as a director of the Group. The completion of the sale is subject to the approval of shareholders at a general meeting and and all other legal and regulatory requirements; the Board will issue a circular to convene this general meeting in due course. Mark Percy, Anita Ghanekar, James Thomas acted as advisor to BATM Advanced Communications.お知らせ • Sep 27BATM Advanced Communications Ltd. Announces Board and Committee ChangesBATM Advanced Communications Ltd. announced that Harel Locker is retiring from his position as an external director, as defined under Israeli law, of the Group with immediate effect. Mr. Locker completes his third three-year term as an external director of BATM. External directors under Israeli law are appointed for a minimum of one three-year term, which may be extended by the company (subject to shareholder approval) for no more than two additional terms of three years each. The Board will propose the appointment of a new external director for approval by shareholders at the Group's next annual general meeting. Following Mr. Locker's retirement from the Board, Prof. Varda Shalev, an external director of BATM, will assume the role of Interim Chair of the Audit Committee and a permanent chair will be appointed in due course.お知らせ • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025お知らせ • Jun 23+ 1 more updateBATM Advanced Communications Ltd. announces resignation of Ran Noy as Director, Effective 23 June 2025BATM Advanced Communications Ltd. announced that Ran Noy has resigned as Chief Financial Officer and a Director of the Group, effective 23 June 2025.お知らせ • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025お知らせ • Dec 19BATM Approves the Appointment of Shmuel Ben Zvi as Non-Executive Director of the GroupBATM at its Annual General Meeting held on 19 December 2024, approved the appointment of Dr. Shmuel (Muli) Ben Zvi as a Non-executive Director of the Group with effect from the conclusion of the Meeting.お知らせ • Dec 12BATM Advanced Communications Limited Announces Commencement of Natslab Molecular Biology PlatformBATM Advanced Communications Limited announced that the NATlab molecular biology platform being developed by ADOR Diagnostics ("ADOR"), an associate company of the Group, has commenced pre-clinical validation at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, Italy. This marks a key milestone in the development of NATlab and, the Group believes, will enable initial sales as well as increase industry awareness and interest from prospective partners. The advanced NATlab molecular biology platform is a point-of-care sample-to-answer solution designed to provide rapid and accurate diagnosis of infectious disease. It uses a patented isothermal amplification method for syndromic multiplex diagnostics to be able to rapidly identify a broad range of pathogens from a single test. The commencement of the pre-clinical validation phase follows the successful completion of pre-clinical trials, which were conducted at the Tzafom Medical Center in Israel, to confirm the validity of the biological process that ADOR has developed and that it can be performed within the NATlab cartridge and analyser device. NATlab identified all negative samples and had a 97% sensitivity for the positive samples, confirming the efficacy of the system and its ability to out-perform competing solutions available in the market because of its multiplex diagnostic capability for rapid and accurate diagnosis. ADOR has now made significant progress with NATlab with the full system entering the pre-clinical validation phase at the Lazzaro Sp allanzani National Institute forinfectious Diseases in Rome, a leading centre for infectious disease research and treatment. Successful completion of the pre-clinical validation is expected to enable initial sales of the NATlab and the commencement of the regulatory process under the European Union In Vitro Diagnostic Medical Device Regulation to become eligible for sale in the EU market. In addition, following the success of the pre-clinical trials, ADOR, in collaboration with the Tzafom Medical center, has received a grant from the Israel Innovation Authority to develop a NATlab panel for the diagnosis of stomach ulcers. The total value is NIS 3.4 million (c. $1 million), which is to be granted over two years based on the achievement of milestones.お知らせ • Nov 15BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israelお知らせ • Aug 19BATM Advanced Communications Ltd. Provides Earnings Guidance for the Second Half of 2024BATM Advanced Communications Ltd. provided earnings guidance for the second half of 2024. For the period, the company expects increase in revenue.お知らせ • May 03BATM Advanced Communications Ltd. Selected for Tb Diagnostics ProgrammeBATM announce that the Group has been selected for aprestigious programme, that is receiving funding from the European Union, for the development of an advanced tuberculosis ("TB") diagnostics solution. The Group has also been awarded a grant of €0.5 million towards the initial 18 months of the programme with the potential for additional funding to be awarded thereafter for the next stage. The Group was selected by the National Research Council of Italy (Consiglio Nazionale delle Ricerche) ("CNR") under a competitive process involving many companies and after a lengthy and detailed verification phase to participate in the programme alongside one of CNR's research institutes, the Institute for System Analysis and Computer Science (Istituto di Analisi dei Sistemi ed Informatica) ("IASI"). The Group's participation reflects its strategy to advance the BATM diagnostics division through developing advanced molecular diagnostics solutions for substantial infectious disease markets, with the global diagnostics market for TB being worth over $2 billion. It is also demonstrative of the steps that the Group is taking to drive long-term sustainable growth through investing in constant innovation to maintain the diagnostics division's technological edge. The programme is for the development of a diagnostics system, based on the Rolling Circle Amplification ("RCA") method, for the rapid identification of TB and multi-drug resistant TB. This builds on the existing work of the BATM diagnostics division for the development of a rapid, RCA-based sample-to-answer diagnostic solution for TB and multi-drug resistant TB. The programme is receiving funding from the European Regional Development Fund via the Lazio Regional Operational Program of the Lazio regional government.お知らせ • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024株主還元BVCL.FUS CommunicationsUS 市場7D0%1.1%2.0%1Yn/a89.3%23.3%株主還元を見る業界別リターン: BVCL.FがUS Communications業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: BVCL.F US市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is BVCL.F's price volatile compared to industry and market?BVCL.F volatilityBVCL.F Average Weekly Movementn/aCommunications Industry Average Movement9.8%Market Average Movement7.2%10% most volatile stocks in US Market16.8%10% least volatile stocks in US Market3.1%安定した株価: BVCL.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のBVCL.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト1992806Moti Nagarwww.batm.comBATM Advanced Communications Ltd.は、その子会社とともに、イスラエル、米国、欧州でリアルタイム技術の開発、製造、マーケティングを行っている。事業セグメントは4つ：サイバー、ネットワーキング、診断、セカンダリー。サイバー部門は、政府、防衛、ミッションクリティカルなネットワーク向けに設計された、ネットワーク暗号化とセキュリティ・コンピューティング・プラットフォームを統合したcGateと、デジタルキーなどの秘密を保護・管理することで、機密データやアプリケーションのセキュリティを提供するハードウェア・セキュリティ・モジュールcHSMからなる、統合されたハードウェアとソフトウェアのソリューションを提供している。ネットワーキング部門は、データ通信製品のマーケティング、研究、開発を行っており、ネットワークのエッジにおけるアプリケーション、ネットワーク機能、コンピュートデバイスの展開とライフサイクル管理を可能にするオープンエッジソフトウェアプラットフォーム「Edgility」や、スイッチングおよびルーティングアプリケーション向けのキャリアグレードのデマケーションおよびアグリゲーション製品群、インフラストラクチャやデバイスの制御・管理用の組み込みソフトウェアなどが含まれる。同部門は、通信事業者、マネージド・サービス・プロバイダー、企業向けに製品を提供している。診断薬事業では、主に中規模検査室、病院、血液バンク向けに体外診断機器、試薬、検査消耗品の開発、販売、流通を行っている。セカンダリー事業では、医薬品、環境モニタリング製品、診断用検査薬の販売、医療・農業・医薬用途の病原性廃棄物処理・滅菌ソリューションの製造を行っている。また、トレーニングやテクニカルサポート、ラボサービスやメンテナンスなどのソフトウェアサービス、建設請負サービスも提供している。BATM Advanced Communications Ltd.は1992年に設立され、イスラエルのホド・ハシャロンに本社を置いている。もっと見るBATM Advanced Communications Ltd. 基礎のまとめBATM Advanced Communications の収益と売上を時価総額と比較するとどうか。BVCL.F 基礎統計学時価総額US$64.56m収益（TTM）-US$12.18m売上高(TTM)US$123.20m0.5xP/Sレシオ-5.3xPER（株価収益率BVCL.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計BVCL.F 損益計算書（TTM）収益US$123.20m売上原価US$83.13m売上総利益US$40.06mその他の費用US$52.25m収益-US$12.18m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.036グロス・マージン32.52%純利益率-9.89%有利子負債／自己資本比率13.6%BVCL.F の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 09:06終値2026/02/25 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BATM Advanced Communications Ltd. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関null nullCavendishSimon StrongPeel Hunt LLPAlasdair YoungShore Capital Group Ltd1 その他のアナリストを表示
お知らせ • Nov 06BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel
お知らせ • Oct 08Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million.DR.Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million on October 6, 2025. Under the terms of the Sale Agreement, the Group will sell AMS to Dr. Zvi Marom, a non-executive director and significant shareholder of the Group, in exchange for his entire shareholding of 96,794,500 ordinary shares of in BATM, representing c. 22.2% of the existing issued share capital. The transaction values AMS at £17.6m, based on the closing price of the Group's Ordinary Shares. Following completion, Dr. Marom will cease to be a shareholder of the Group and will resign as a director of the Group. The completion of the sale is subject to the approval of shareholders at a general meeting and and all other legal and regulatory requirements; the Board will issue a circular to convene this general meeting in due course. Mark Percy, Anita Ghanekar, James Thomas acted as advisor to BATM Advanced Communications.
お知らせ • Sep 27BATM Advanced Communications Ltd. Announces Board and Committee ChangesBATM Advanced Communications Ltd. announced that Harel Locker is retiring from his position as an external director, as defined under Israeli law, of the Group with immediate effect. Mr. Locker completes his third three-year term as an external director of BATM. External directors under Israeli law are appointed for a minimum of one three-year term, which may be extended by the company (subject to shareholder approval) for no more than two additional terms of three years each. The Board will propose the appointment of a new external director for approval by shareholders at the Group's next annual general meeting. Following Mr. Locker's retirement from the Board, Prof. Varda Shalev, an external director of BATM, will assume the role of Interim Chair of the Audit Committee and a permanent chair will be appointed in due course.
お知らせ • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025
お知らせ • Jun 23+ 1 more updateBATM Advanced Communications Ltd. announces resignation of Ran Noy as Director, Effective 23 June 2025BATM Advanced Communications Ltd. announced that Ran Noy has resigned as Chief Financial Officer and a Director of the Group, effective 23 June 2025.
お知らせ • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025
お知らせ • Nov 06BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel
お知らせ • Oct 08Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million.DR.Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million on October 6, 2025. Under the terms of the Sale Agreement, the Group will sell AMS to Dr. Zvi Marom, a non-executive director and significant shareholder of the Group, in exchange for his entire shareholding of 96,794,500 ordinary shares of in BATM, representing c. 22.2% of the existing issued share capital. The transaction values AMS at £17.6m, based on the closing price of the Group's Ordinary Shares. Following completion, Dr. Marom will cease to be a shareholder of the Group and will resign as a director of the Group. The completion of the sale is subject to the approval of shareholders at a general meeting and and all other legal and regulatory requirements; the Board will issue a circular to convene this general meeting in due course. Mark Percy, Anita Ghanekar, James Thomas acted as advisor to BATM Advanced Communications.
お知らせ • Sep 27BATM Advanced Communications Ltd. Announces Board and Committee ChangesBATM Advanced Communications Ltd. announced that Harel Locker is retiring from his position as an external director, as defined under Israeli law, of the Group with immediate effect. Mr. Locker completes his third three-year term as an external director of BATM. External directors under Israeli law are appointed for a minimum of one three-year term, which may be extended by the company (subject to shareholder approval) for no more than two additional terms of three years each. The Board will propose the appointment of a new external director for approval by shareholders at the Group's next annual general meeting. Following Mr. Locker's retirement from the Board, Prof. Varda Shalev, an external director of BATM, will assume the role of Interim Chair of the Audit Committee and a permanent chair will be appointed in due course.
お知らせ • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025
お知らせ • Jun 23+ 1 more updateBATM Advanced Communications Ltd. announces resignation of Ran Noy as Director, Effective 23 June 2025BATM Advanced Communications Ltd. announced that Ran Noy has resigned as Chief Financial Officer and a Director of the Group, effective 23 June 2025.
お知らせ • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025
お知らせ • Dec 19BATM Approves the Appointment of Shmuel Ben Zvi as Non-Executive Director of the GroupBATM at its Annual General Meeting held on 19 December 2024, approved the appointment of Dr. Shmuel (Muli) Ben Zvi as a Non-executive Director of the Group with effect from the conclusion of the Meeting.
お知らせ • Dec 12BATM Advanced Communications Limited Announces Commencement of Natslab Molecular Biology PlatformBATM Advanced Communications Limited announced that the NATlab molecular biology platform being developed by ADOR Diagnostics ("ADOR"), an associate company of the Group, has commenced pre-clinical validation at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, Italy. This marks a key milestone in the development of NATlab and, the Group believes, will enable initial sales as well as increase industry awareness and interest from prospective partners. The advanced NATlab molecular biology platform is a point-of-care sample-to-answer solution designed to provide rapid and accurate diagnosis of infectious disease. It uses a patented isothermal amplification method for syndromic multiplex diagnostics to be able to rapidly identify a broad range of pathogens from a single test. The commencement of the pre-clinical validation phase follows the successful completion of pre-clinical trials, which were conducted at the Tzafom Medical Center in Israel, to confirm the validity of the biological process that ADOR has developed and that it can be performed within the NATlab cartridge and analyser device. NATlab identified all negative samples and had a 97% sensitivity for the positive samples, confirming the efficacy of the system and its ability to out-perform competing solutions available in the market because of its multiplex diagnostic capability for rapid and accurate diagnosis. ADOR has now made significant progress with NATlab with the full system entering the pre-clinical validation phase at the Lazzaro Sp allanzani National Institute forinfectious Diseases in Rome, a leading centre for infectious disease research and treatment. Successful completion of the pre-clinical validation is expected to enable initial sales of the NATlab and the commencement of the regulatory process under the European Union In Vitro Diagnostic Medical Device Regulation to become eligible for sale in the EU market. In addition, following the success of the pre-clinical trials, ADOR, in collaboration with the Tzafom Medical center, has received a grant from the Israel Innovation Authority to develop a NATlab panel for the diagnosis of stomach ulcers. The total value is NIS 3.4 million (c. $1 million), which is to be granted over two years based on the achievement of milestones.
お知らせ • Nov 15BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel
お知らせ • Aug 19BATM Advanced Communications Ltd. Provides Earnings Guidance for the Second Half of 2024BATM Advanced Communications Ltd. provided earnings guidance for the second half of 2024. For the period, the company expects increase in revenue.
お知らせ • May 03BATM Advanced Communications Ltd. Selected for Tb Diagnostics ProgrammeBATM announce that the Group has been selected for aprestigious programme, that is receiving funding from the European Union, for the development of an advanced tuberculosis ("TB") diagnostics solution. The Group has also been awarded a grant of €0.5 million towards the initial 18 months of the programme with the potential for additional funding to be awarded thereafter for the next stage. The Group was selected by the National Research Council of Italy (Consiglio Nazionale delle Ricerche) ("CNR") under a competitive process involving many companies and after a lengthy and detailed verification phase to participate in the programme alongside one of CNR's research institutes, the Institute for System Analysis and Computer Science (Istituto di Analisi dei Sistemi ed Informatica) ("IASI"). The Group's participation reflects its strategy to advance the BATM diagnostics division through developing advanced molecular diagnostics solutions for substantial infectious disease markets, with the global diagnostics market for TB being worth over $2 billion. It is also demonstrative of the steps that the Group is taking to drive long-term sustainable growth through investing in constant innovation to maintain the diagnostics division's technological edge. The programme is for the development of a diagnostics system, based on the Rolling Circle Amplification ("RCA") method, for the rapid identification of TB and multi-drug resistant TB. This builds on the existing work of the BATM diagnostics division for the development of a rapid, RCA-based sample-to-answer diagnostic solution for TB and multi-drug resistant TB. The programme is receiving funding from the European Regional Development Fund via the Lazio Regional Operational Program of the Lazio regional government.
お知らせ • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024
